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Background/aim: The aim of the present study is to investigate the effects of cigarette smoke (CS) and simultaneous application of
resveratrol on bone healing histomorphometrically and to evaluate the effects of resveratrol on negative effects of CS.
Materials and methods: For 4 weeks, Sprague Dawley rats were exposed to cigarette smoke at the equivalent of 6 cigarettes per day.
After this period, monocortical defects were created in femurs by a trephine bur on day 28. Starting from the day of defect creation to the
28th postoperative day, rats were given 20 mg/kg body weight resveratrol. Histomorphometric examination of the number of osteoblasts
and osteoclasts, as well as new bone area, was conducted.
Results: Investigations were carried out on 33 rats. Differences between osteoblast numbers in the control and CS groups were significant,
and CS caused a reduction in the number of osteoblasts. Areas of new bone formation in the resveratrol and control groups were higher
than in the smoking and smoking+resveratrol groups.
Conclusion: Smoking appeared to have adverse effects upon bone healing and resveratrol administration helped to reduce these effects.
Key words: Cigarette smoking, resveratrol, new bone area, osteoblast, osteoclast

1. Introduction
Bone healing is a complex process influenced by biological,
mechanical, and systemic factors. Delays in bone healing
affect the success of almost all oral surgical procedures.
Bone healing may be decelerated for various reasons or
may result in formation of fibrous tissue (1).
Cigarette smoke (CS) disrupts bone healing, can lead
to osteoporosis, and affects the planning and success of
surgical procedures. The effect of CS on bone metabolism
could be via disorders in bone angiogenesis, collagen
metabolism, and the RANK–RANKL–osteoprotegerin
(OPG) system (2,3). Direct cellular effects of CS on bone
include changes in calciotropic hormone metabolism
(4). Osteocalcin can be affected by CS directly or by
hormonal changes and may decrease osteoblast activity
(5). Fung et al. (6) reported that nicotine (active ingredient
of cigarettes) reduced vitamin D storage and osteoblast
activity in humans.
Resveratrol (trans-3,4,5-trihydroxystilbene), a natural
polyphenol, is a plant metabolite found in grapes and wine,
with osteogenic, antioxidant, antiinflammatory, analgesic,
and antiaging effects (7–9). In vitro studies have shown
* Correspondence: mugecina@hotmail.com

that resveratrol inhibits osteoclast differentiation, increases
formation of osteoblasts, and stimulates expression of the
vitamin D receptor in bone marrow osteoblast precursor
cells (10,11). Studies using various vitamins and hormones
to reduce or eliminate the negative effects of CS on the
healing and metabolism of bone have been published
(12,13). However, these substances affect only osteoblasts
or osteoclasts.
The aim of the present study is to investigate the effects
of CS and simultaneous application of resveratrol on bone
healing histomorphometrically and to evaluate the effects
of resveratrol on negative effects of CS.
2. Materials and methods
2.1. Study design
Thirty-eight Sprague Dawley rats (6 months; 250–300 g)
were obtained from the Experimental Animal Production
and Experimental Research Laboratory of Süleyman
Demirel University. The experiment was performed
with the approval of the Ethics Committee on Animal
Experiments of Süleyman Demirel University (date and
number, 14.08.2012-10). Rats were placed in plastic cages
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according to standard conditions (21–22 °C; humidity,
50%; 12-h light/dark cycle). They were fed a standard
pellet diet and tap water. Rats were divided randomly into
four groups.
In the first 4 weeks of the study, CS exposure groups
(groups 2 and 4) were exposed to cigarettes (Tekel 2000;
İstanbul, Turkey) containing tar (10 mg), nicotine (1 mg),
and carbon monoxide (10 mg) in glass cages of dimensions
of 75 × 75 × 50 cm. Nonsmoking rats were exposed to
room air in separate glass cages so that they experienced
the same level of stress.
CS was produced in a glass smoke generator with
an open bottom fitted to a cap covering the chamber.
Cigarettes were burned in a filter and spilling of ash into
the cage was not possible. The smoke generator was a
reservoir with a 2-cm2 opening at the top and dimensions
of 25 × 15 × 15 cm. CS was produced by the burning of
one cigarette/10 min in the open-base chamber. Smoke
arising from the filter and the end of the cigarette was
aspirated into the cage with the help of the fan fixed on
the glass cover. All smoke in the upper part of the smoke
generator was aspirated by a fan placed in the opening of
the glass chamber (Figure 1). The CS experimental model
was designed by the authors. The glass cage was ventilated
for 5 min after each cigarette was burned. There were two
sessions every day, and rats were exposed to the smoke of
six cigarettes.
2.2. Surgical procedures
General anesthesia was induced with an intraperitoneal
injection of 80 mg/kg body weight ketamine hydrochloride
(Alpha®; Aegean-Vet, Turia, Spain). The surgical area
was shaved and skin disinfected with a 10% povidone
iodine solution. Under sterile conditions, a skin incision
of about 1 cm in length was made with blunt dissection.
The periosteum was elevated and reached the surface
of the right femur. Using a standard trephine bur under

irrigation with 0.9% (physiological) saline, a monocortical
defect (diameter: 3 mm) was osteotomized from the
femur. Amikacin sulfate (5 mg/kg body weight daily,
i.m.; Amikozit®, Zentiva, Turkey) was given for infection
control, and ketoprofen (3 mg/kg body weight daily, i.m.;
Profenid® bulb, Sanofi-Aventis, İstanbul, Turkey) was
administered for pain control for 5 days after surgery.
According to the manufacturer’s recommendations,
resveratrol (Sigma-Aldrich, Saint Louis, MO, USA) was
dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich)
at a ratio of 16 mg resveratrol/1 mL DMSO. Resveratrol
solution was prepared fresh every day. After drawing
resveratrol solution (20 mg/kg) into an insulin syringe,
1 mL of water was also drawn and administered by
intragastric gavage to groups 3 and 4 for 4 weeks during
the bone healing period, after surgery. Groups 1 and
2 were given only DMSO (diluted). CS exposure was
continued during the bone healing period, after surgery.
Rats were sacrificed at week 8. Right femurs were dissected
and stored in 10% formalin.
2.3. Histomorphometric evaluation
Samples prepared for histomorphometric evaluation
were stained with hematoxylin and eosin (H&E) and
assessed using an Eclipse E400 Light Microscope (Nikon,
Tokyo, Japan). A Coolpix 5000 Digital Camera (Nikon)
was connected to the light microscope and samples were
photographed during evaluation. Photographs taken at the
same magnification with an MBM11100 Stage Micrometer
Type A (Nikon) were recorded as digital images. All
images were transferred to a personal computer and
evaluated with Vision Lite 3.5 Image Analysis software
(Clemex Technologies, Longueuil, Canada). In each
case, osteoblasts and osteoclasts in an area of 562,375.2
µm2 were marked with the image analysis system and
counted automatically (Figure 2). On the same unit areas,
formation of new bone was calculated by Vision Lite 3.5

Figure 1. The experimental cigarette smoking model.

Figure 2. Histomorphometric evaluation, osteoblasts (OB) and
osteoclasts (OC) (H&E).
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Image Analysis. All histomorphometric analyses were
undertaken by the same pathologist, who was blinded to
the study protocol.
2.4. Statistical analyses
Statistical analyses were carried out using SPSS 18.0
(SPSS Inc., Chicago, IL, USA). Numbers of osteoblasts
and osteoclasts were evaluated using one-way analysis
of variance. Differences between groups were evaluated
with the Tukey test. The Kruskal–Wallis test was used to
evaluate the area of new bone formation. The Bonferroni–
Dunn test was employed to determine differences in mean
values between groups. P ≤ 0.05 was considered significant.
3. Results
Of 38 rats, two died during the induction of anesthesia, two
died due to the formation of perforations after intragastric
gavage, and one was excluded from the study due to femur
fracture of the defect line. Hence, investigations were
carried out on 33 animals. No complications, osteomyelitis,
abscess formation, or wound openings were seen after the
surgical procedure to the time of euthanasia.

The highest number of osteoblasts was in the
resveratrol group, and the difference between CS groups
was significant. The differences between the osteoblast
numbers of the control and CS groups were significant,
and CS caused a reduction in the number of osteoblasts
(Table 1).
Differences between the number of osteoclasts in the
control group and CS group were significant (P < 0.05).
The largest number of osteoclasts was in the control group,
followed by the resveratrol group and CS+resveratrol
group. The lowest number of osteoclasts was in the CS
group (Table 2).
Data on new bone formation were transformed
logarithmically and provided the preconditions of
parametric testing. The results of the Kruskal–Wallis test
at P < 0.05 indicated no significant difference between
average values of the groups (P = 0.074), but the largest
area of new bone was in the resveratrol group. Areas of
new bone formation in the resveratrol and control groups
were higher than in the CS and CS+resveratrol groups
(Table 3).

Table 1. The results of osteoblast numbers between study groups.
Group

N

Mean

St Dev

Min

Max

C1

8

57.88ab

15.33

42.0

87.0

9

38.11

9.6

22.0

51.0

8

75.25a

24.89

44.0

119.0

8

48.88

10.11

37.0

71.0

CS

2

R3
CS+R

4

c

bc

C, control; 2CS, cigarette smoke; 3R, resveratrol; 4CS+R, cigarette smoke and resveratrol.
Differences between groups were evaluated with the Tukey test. Statistical differences
are indicated with superscript letters. Statistically significant differences between the
groups and osteoblast numbers are stated with different letters (P < 0.05).

1

Table 2. The results of osteoclast numbers between study groups.
Group

N

Mean

St Dev

Min

Max

C1

8

4.000a

1.927

2.0

8.0

CS2

9

2.444b

0.726

1.0

3.0

R3

8

3.750ab

1.581

2.0

7.0

CS+R4

8

2.625ab

0.916

1.0

4.0

C, control; 2CS, cigarette smoke; 3R, resveratrol; 4CS+R, cigarette smoke and resveratrol.
Differences between groups were evaluated with the Tukey test. Statistical differences
are indicated with superscript letters. Statistically significant differences between the
groups and osteoblast numbers are stated with different letters (P < 0.05).

1
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Table 3. The results of new bone area between study groups.
Group

N

Mean

Mean Rank

St Dev

Min

Max

C

8

1,429,279

21.0

605,549

532,283

2,377,681

9

847,179

11.9

743,041

42,348

2,460,250

R3

8

1,506,195

22.0

746,670

485,277

2,716,080

CS+R4

8

884,297

13.8

215,486

664,151

1,266,354

1

CS

2

C, control; 2CS, cigarette smoke; 3R, resveratrol; 4CS+R, cigarette smoke and resveratrol.
The Kruskal–Wallis test was used to evaluate the area of new bone formation. There is no statistical difference
between groups and new bone area (P = 0.074).

1

4. Discussion
Bone healing after surgical procedures results in the
achievement of bone structure and biomechanical strength.
Bone healing is based on osteoblast differentiation into
osteogenic cells as well as their proliferation and migration
(14). CS influences bone metabolism by disrupting
osteoblast formation and increasing osteoclast resorption
(5,15).
Studies on bone healing have suggested that 4 weeks is
an appropriate period to observe osteoblasts, osteoclasts,
and new bone formation (16,17). Bone healing evaluated
in the 4-week period suggests that osteoblasts are active
and that new bone remodeling occurs in the defect.
Maxillofacial surgical procedures performed in rats can
cause severe malnutrition and general weakness. Histing
et al. (18) reported that because of the easier surgical
manipulation of the long bones, the femur or tibia can be
preferred as a bone healing model.
Nicotine changes bone histology by inhibiting
osteoblastic cells and disrupting PTH levels, causing
tissue ischemia with increased platelet adhesion and
microvascular congestion, decreasing bone density, and
decreasing storage of vitamin D (6). Cadmium can also
decrease bone density (19). Fracture healing and bone-graft
recovery is disrupted in cigarette smokers and, in healed
bones, tensile strength is decreased significantly (20–22).
CS influences bone cells directly and is detrimental to bone
formation because it inhibits osteoblast differentiation
(1,23).
It has been suggested that aryl hydrocarbons in
cigarettes might influence bone metabolism. Aryl
hydrocarbons inhibit osteoblast differentiation and induce
osteoclastic bone resorption. Resveratrol is a strong aryl
hydrocarbon receptor antagonist and might reduce the
inhibition of osteoblastogenesis and osteoclast formation
caused by aryl hydrocarbons (15,23).
In addition to the antioxidant, antiinflammatory,
antiaging, and anticarcinogenic characteristics of
resveratrol, it is a plant metabolite with positive influences
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on bone metabolism (7–9). Studies have shown that
resveratrol stimulates expression of the vitamin D receptor
in bone marrow cells, increases osteoblast differentiation
while inhibiting osteoclasts, and accelerates bone healing
(10,11,24). It has been reported that the antiinflammatory
effect of resveratrol prevents the bone resorption caused by
the increase in osteoclast activation related to oversecretion
of inflammatory mediators (25).
In the present study, after forming a subchronic CS
model, resveratrol was given at 20 mg/kg body weight
daily over 28 days. Numbers of osteoblasts and osteoclasts,
as well as new bone area, were evaluated. The number of
osteoblasts was greatest in the resveratrol group and lowest
in the smoking group (P < 0.05). Our research shows that
resveratrol increases osteoblast formation. This result is
in accordance with those of Liu et al. (1) and Boissy et al.
(10) showing that resveratrol increases osteoblastogenesis
in vitro. In addition, it could be thought that resveratrol
“corrected” the decrease in the number of osteoblasts in
the CS+resveratrol group.
The largest number of osteoclasts was in the control
group, followed by the resveratrol group and the
CS+resveratrol group. The lowest number of osteoclasts
was in the CS group. Moreover, the number of osteoclasts
in the resveratrol group was lower than in the control
group. These results could be related to the inhibition of
osteoclasts by resveratrol and are in accordance with the
work of Boissy et al. (10) and Iqbal et al. (15).
In vitro and in vivo studies have evaluated the effects
of resveratrol on bone formation. Those investigations
suggested that resveratrol increased osteoblastogenesis
and new bone formation (26,27). CS has been reported to
cause hormonal changes, oversecretion of inflammatory
cytokines, changes in levels of growth factors, and OPG
inhibition. As a result, the balance between osteoblasts and
osteoclasts is disrupted and, eventually, this might reduce
new bone formation (28,29). Uysal et al. (30) injected a
single dose of resveratrol (10 µmol/kg) into the maxillary
suture of rats, to which intermaxillary suture extension
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was conducted. They found that the new bone area and
osteoblast numbers in the resveratrol-injected group were
significantly greater than those of the control group.
Despite the absence of a significant difference (P =
0.07) between groups, new bone area was greatest in the
resveratrol group and least in the CS group. This result
supports the results of Andrade et al. (14), who found
that CS diminished the bone volume of rats exposed to six
cigarettes per day over 10 weeks.
Thus far, no in vivo study has been conducted to
investigate the effects of both CS and resveratrol on bone
healing, and the effects of resveratrol and CS on bone cells
have been described in independent in vitro studies. In
this in vivo study conducted in accordance with previous

studies performed at the cellular level, simultaneous
application of resveratrol may have stimulated bone
formation and it could be thought that resveratrol reduces
the adverse effects of smoking on bone healing. Further
biochemical and clinical studies are necessary to validate
its effects on smoking patients and also to ascertain
whether it should be used prophylactically.
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